高级检索
当前位置: 首页 > 详情页

Involvement of Notch1/Hes signaling pathway in ankylosing spondylitis

| 认领 | 导出 |

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Shanghai Jiao Tong Univ, Sch Med, Tongren Hosp, Dept Orthoped Surg, Shanghai 200336, Peoples R China
出处:
ISSN:

关键词: Notch1 hairy enhancer of split hip joint ligament ankylosing spondylitis mRNA expressions protein expressions clinical course signaling pathway

摘要:
We aimed to investigate the role of Notch1/Hes signaling pathway in the pathogenesis of abnormal ossification of hip ligament in patients with ankylosing spondylitis (AS). 22 AS patients scheduled for artificial hip arthroplasty were randomly chosen as AS group. As controls, we used 4 patients diagnosed with transcervical fracture who underwent hip replacement surgery. Notch1 and Hes mRNA expressions were detected by real-time fluorescent quantitative polymerase chain reaction (RFQ-PCR). Immunohistochemistry (IHC) was used to detect Notch1 and Hes protein expression. Correlation analyses of Notch-l and Hes with AS-related clinical factors were conducted with spearman's correlation analysis and partial correlation analysis. RFQ-PCR results showed significant differences in Notch1 and Hes mRNA expressions between AS group and the control group (all P < 0.05). IHC analysis further indicated positive nuclear signals of Notch1 and Hes protein, indicating functional activation of the Notch1 and Hes pathways. Semi-quantitative IHC showed a higher Notch1 and Hes expression levels in AS group compared to the control group (all P < 0.05). Correlation analysis suggested that Hes protein expression was positively associated with the clinical course of the disease in AS patients. In conclusion, Notch1 and Hes overexpression was clearly detected in hip joint ligaments of AS patients, Hes protein expression was associated with the clinical course of AS. Taken together, we suggest that signaling pathways mediated by Notch1-Hes may contribute to ligament ossification of hip joints in AS patients.

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2014]版:
大类 | 4 区 医学
小类 | 4 区 肿瘤学 4 区 病理学
最新[2023]版:
JCR分区:
出版当年[2013]版:
Q3 ONCOLOGY Q3 PATHOLOGY
最新[2023]版:
Q3 PATHOLOGY Q4 ONCOLOGY Q4 PATHOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2013版] 出版当年五年平均 出版前一年[2012版] 出版后一年[2014版]

第一作者:
第一作者机构: [1]Shanghai Jiao Tong Univ, Sch Med, Tongren Hosp, Dept Orthoped Surg, Shanghai 200336, Peoples R China
通讯作者:
通讯机构: [1]Shanghai Jiao Tong Univ, Sch Med, Tongren Hosp, Dept Orthoped Surg, Shanghai 200336, Peoples R China [*1]Shanghai Jiao Tong Univ, Sch Med, Tongren Hosp, Dept Orthoped Surg, 1111 Xianxia Rd, Shanghai 200336, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:21169 今日访问量:0 总访问量:1219 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)